GERIAMED

What GERIAMED does

GERIAMED is a French professional services firm headquartered in Boulogne-Billancourt, founded in 2013 by Dimitri Verza, specializing exclusively in geriatric medicine consulting for the pharmaceutical industry. The firm is structured around five service pillars: strategic and scientific consulting, business intelligence (including market research and forecasting), scientific communication, medical education, and scientific publishing. Its most significant intangible asset is stewardship of La Revue de Gériatrie, the official journal of three French geriatric medical societies (SFGG, CNEG, SNGC), published since 1976 with a circulation of 2,500 subscribers across 10 annual issues.

The company serves a concentrated roster of pharmaceutical laboratories—including Novartis, Boehringer Ingelheim, Novo Nordisk, Amgen, LEO, Astellas, Norgine, Biocodex, Therabel, and 3M—alongside French public health and medical society stakeholders (SFGG, CNEG, SNGC, CNSA). Service delivery products include Géria'care (medical education platform), Geriatrie.Tv (webTV channel), NITH (business intelligence), Bourse de recherche (research grants), and TAP (Therapeutic Area Programs) available in French and English. The firm executes over 100 projects annually.

The business model is a hybrid of professional services consulting (project-based engagements with pharmaceutical clients) and subscription publishing (La Revue de Gériatrie). Operations are supported by a small core team of five employees, including specialized leadership: Dimitri Verza as President, Frédéric Ville as Director of Consulting and Business Development, Caroline Spasojevic as Scientific Director, and Bénédicte Agius. The firm carries no disclosed external funding and operates as a self-sustaining SAS with minimal share capital (€14,560), indicating a lifestyle-scale consultancy rather than a venture-backed growth company.

Name

GERIAMED

Legal name

GERIAMED

Website

https://geriamed.fr

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

GERIAMED is a 5-person French consulting firm offering strategic, scientific, and medical communications services exclusively to pharmaceutical companies and geriatric medical societies, anchored by stewardship of La Revue de Gériatrie.

Ownership category

akta.pro rank

Headquarters

HQ city

Boulogne-Billancourt

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Strategic and Scientific Consulting: Consulting services providing strategic and operational support for pharmaceutical companies throughout product life cycle management in geriatric healthcare.
2. Medical Education Services: Training programs for pharmaceutical company teams including initial and continuous formats, selling village programs, and immersion programs.
3. Publishing and Medical Writing: Publication of La Revue de Gériatrie (10 issues/year), medical writing services, and editorial solutions for congress coverage.
4. Scientific Communication Services: Communication product tools, RP programs, MOOC production, and scientific insertion services.
5. Market Research and Business Intelligence: Quantitative and qualitative market studies, sales force effectiveness consulting, segmentation, targeting, and performance analysis.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

GERIAMED is a consulting firm dedicated to geriatric medicine that supports pharmaceutical companies throughout the product life cycle. Its offerings span five pillars: strategic and scientific consulting, business intelligence and market research, scientific communication, medical education/training, and the publication of La Revue de Gériatrie (official journal of SFGG, CNEG, and SNGC, founded in 1976 with 2,500 subscribers). Services are tailored for pharmaceutical laboratories and medical/scientific societies.

Product overview

GERIAMED is a consulting company dedicated to geriatric medicine, offering a comprehensive suite of services organized around five core pillars: strategic and scientific consulting, business intelligence, scientific communication, medical education, and publishing/medical writing. The company publishes La REVUE de Gériatrie as its flagship product—an official journal of major French geriatric societies. Its product portfolio includes medical education programs (Géria'care, Geriatrie.Tv, Bourse de recherche), business intelligence tools (NITH, Market Research, Sales Force Effectiveness), and scientific communication services (TAP formats, Insertion d'informations). GERIAMED positions itself as a full-service partner for pharmaceutical companies seeking to develop products and strategies targeting elderly patients throughout the product lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

• La Revue de Gériatrie Official French-language scientific journal of geriatric medicine, published by GERIAMED as the official organ of the Société Française de Gériatrie et Gérontologie (SFGG), the Collège National des Enseignants de Gériatrie (CNEG), and the Syndicat National de Gérontologie Clinique (SNGC). Distributed to 2,500 professional subscribers and issued 10 times per year. CPPAP: 0124 X 92217.
• Géria'care Medical training program for pharmaceutical laboratory teams, offered in initial and continuing education formats, with integration of patient pathways and immersion experiences for medical, marketing and sales functions.
• Geriatrie.Tv WebTV platform dedicated to geriatric medicine providing video coverage of major geriatrics congresses and educational materials for healthcare professionals and pharmaceutical laboratory teams.
• NITH (Business Intelligence Service) Business intelligence service providing market analysis and strategic insights tailored for pharmaceutical companies operating in the geriatric sector.
• Market Research Quantitative and qualitative market research studies for decision-makers in the pharmaceutical industry targeting the geriatric market.
• Sales Force Effectiveness (SFE) Consulting service for sales force efficiency, segmentation, targeting, analysis, and performance management for pharmaceutical laboratory field teams in geriatrics.
• TAP Format francophone French-language scientific communication program and editorial format for disseminating geriatric scientific content.
• TAP Format anglophone English-language scientific communication program and editorial format for disseminating geriatric scientific content.
• Insertion d'informations Service for inserting scientific information within publications and communication materials produced for pharmaceutical laboratories and medical societies.
• Bourse de recherche (Research Grant Program) Research grant program supporting scientific communication and research initiatives in geriatrics.

Quantifiable outcome

• 2,500 subscribers to La Revue de Gériatrie
• +3 more outcomes

Named customers14 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Société Française de Gériatrie et Gérontologie (SFGG)coreStrategic or Co-development PartnerOfficial publishing partner for La Revue de Gériatrie - the official publication organ of SFGG. Deep collaboration in scientific content and geriatric expertise dissemination.
• Collège National des Enseignants de Gériatrie (CNEG)coreStrategic or Co-development PartnerOfficial publishing partner - La Revue de Gériatrie serves as official organ for CNEG educational content and teaching materials.
• Syndicat National de Gérontologie Clinique (SNGC)coreStrategic or Co-development PartnerOfficial publishing partner for SNGC - La Revue de Gériatrie serves as official publication organ.
• 3MminorGTM or Marketing PartnerLaboratory partner trusting GERIAMED services.
• Boehringer IngelheimminorGTM or Marketing PartnerMajor pharmaceutical company partner for geriatric consulting services.
• Novo NordiskminorGTM or Marketing PartnerLaboratory partner for geriatrics consulting services.
• AmgenminorGTM or Marketing PartnerPharmaceutical laboratory partner.
• NovartisminorGTM or Marketing PartnerLaboratory partner.
• CNSA (Caisse Nationale de Solidarité pour l'Autonomie)minorStrategic or Co-development PartnerInstitutional partner in geriatric healthcare.
• Médéric AlzheimerminorStrategic or Co-development PartnerInstitutional partner focused on Alzheimer's disease.

Scale indicators8 records

Recent moves6 records

Expansion highlights4 records

Emerging players

• Inato: Inato is a French-founded healthtech platform connecting pharma sponsors with clinical research sites. While focused on clinical operations rather than consulting, it shares GERIAMED's small-scale French pharma-services profile and emerging-player status.

Direct peers

• Observia: Observia is a French health consultancy focused on patient-centric solutions, behavior change, and digital health — directly serving pharma clients from a small French base with comparable boutique consulting profile.
• Cemka Eval: Cemka is a French health economics and market access consulting firm serving pharmaceutical companies, similar in size and positioning to GERIAMED. Both are boutique French pharma consultancies with deep therapeutic expertise.
• Medi-Scope: Medi-Scope is a French healthcare communications and consulting agency serving pharma clients, with similar boutique scale and a focus on specialized therapeutic areas. Directly comparable on service model and target customer.

Broad incumbents

• Havas Health & You: Havas Health & You is the global healthcare communications network of Havas, providing scientific communications, medical education, and consulting services to pharma clients. Comparable offering to GERIAMED across all five service pillars but at global scale.
• Ogilvy Health: Ogilvy Health is the global healthcare communications arm of WPP, providing medical education, scientific communications, and brand strategy to pharma clients worldwide. Directly comparable service categories to GERIAMED but with much broader scope.
• IQVIA: IQVIA is the global leader in pharma commercial services, providing market research, sales force effectiveness, and consulting across the entire product life cycle. GERIAMED's NITH/Market Research/SFE offerings directly overlap with IQVIA's commercial services portfolio.
• Publicis Health: Publicis Health is the healthcare arm of Publicis Groupe, a global pharma marketing and communications network serving major pharmaceutical companies across multiple therapeutic areas. Overlaps with GERIAMED's pharma comms and medical education offerings but at vastly larger scale.
• McCann Health: McCann Health is a global healthcare communications network providing medical education, scientific communications, and brand strategy to pharma clients. Overlapping with GERIAMED's medical education and scientific communication pillars.
• McKinsey Healthcare Practice: McKinsey's Healthcare Practice advises pharma clients on commercial strategy, market access, and life-cycle management — directly comparable to GERIAMED's strategic consulting pillar but at vastly larger scale and broader therapeutic scope.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/geriamed

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GERIAMED